Efficacy and Safety of Omija (<i>Schisandra chinensis</i>) Extract Mixture on the Improvement of Hyperglycemia: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial.

Kim, Da-Som; Baek, Hyang-Im; Ha, Ki-Chan; Cha, Youn-Soo; Park, Soo-Jung

Efficacy and Safety of Omija (Schisandra chinensis) Extract Mixture on the Improvement of Hyperglycemia: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial.

Kim, Da-Som; Baek, Hyang-Im; Ha, Ki-Chan; Cha, Youn-Soo; Park, Soo-Jung.

Afiliación

Kim DS; Healthcare Claims & Management Incorporation, Jeonju 54858, Korea.
Baek HI; Departments of Food Science & Human Nutrition, Jeonbuk National University, Jeonju 54896, Korea.
Ha KC; Healthcare Claims & Management Incorporation, Jeonju 54858, Korea.
Cha YS; Department of Food Science & Nutrition, Woosuk University, Wanju 55338, Korea.
Park SJ; Healthcare Claims & Management Incorporation, Jeonju 54858, Korea.

Nutrients ; 14(15)2022 Jul 30.

Article en En | MEDLINE | ID: mdl-35956334

Asunto(s)

Diabetes Mellitus Tipo 2; Hiperglucemia; Schisandra; Glucemia; Diabetes Mellitus Tipo 2/tratamiento farmacológico; Método Doble Ciego; Fructosamina; Hemoglobina Glucada/análisis; Humanos; Hiperglucemia/tratamiento farmacológico; Hipoglucemiantes/efectos adversos; Insulina

Palabras clave

Omija; Omija extract mixture; Schisandra chinensis; clinical trial; glycemic control; soybean; type 2 diabetes

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Schisandra / Diabetes Mellitus Tipo 2 / Hiperglucemia Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Nutrients Año: 2022 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google